Back to recent news
StellarQ Oy and Medino Oy Launch Strategic Collaboration Project Supported by EU Regional Funding – January 2026
StellarQ Oy and Medino Oy have initiated a strategic collaboration project supported by an EU Regional Funding Program (ERFP). The one-year project will commence in January 2026 and supports StellarQ’s preparation for international expansion into the Nordic countries and more broadly across the European Union.
The objective of the project is to explore and develop international opportunities for standardized care follow-up models in long-term diseases that impose a significant economic and societal burden. The collaboration will focus on two pilot conditions: Alzheimer’s disease and sleep apnea.
During the project, the project group will assess current care pathways, follow-up structures, data utilization practices, and opportunities to create scalable and internationally applicable models for systematic long-term disease monitoring.
The initiative aims to strengthen evidence-based, cost-effective, and patient- centered follow-up practices while supporting the international growth and scalability of StellarQ’s treatment platform services.
Honored to contribute to building StellarQ’s international strategy and key initiatives to help healthcare providers and patients achieve best possible treatment outcomes in Alzheimer’s disease and sleep apnea care, particularly in the Nordic countries.Marco Hautalahti, CEO of Medino oy
Proud to strengthen this collaboration with Medino as we build on StellarQ’s strong nationwide use and take our next steps toward international expansion. This project enables us to scale our treatment follow-up models in conditions with high societal burden, specifically in Alzheimer’s disease and sleep apnea.Markku Aittokallio, CEO of StellarQ oy
Read more about Medino oy here: https://medino.fi/